| |
| |
|
| Insider
Information: |
Ramsay David A |
| Relationship: |
Director |
| City: |
San Diego, |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
2,587,962 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$27,245,654 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
2,587,962 |
|
|
| Total
Value |
$27,245,654 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
54
|
0
|
|
Stock
price went up :
|
46
|
0
|
| Stock
price went down : |
8
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
5.8
|
0.0
|
| Percentage
Gain/Loss : |
 71.9%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Halozyme Therapeutics Inc |
HALO |
VP and Chief Financial... |
2015-02-06 |
364,320 |
|
0 |
Premium* |
|
|
Savara Inc |
SVRA |
Director |
2023-12-14 |
2,223,642 |
2012-05-09 |
0 |
Premium* |
|
|
La Jolla Pharmaceutical Co |
LJPC |
Director |
2022-08-22 |
0 |
2020-08-20 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
93 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| HALO |
Halozyme Therapeutics Inc |
Vice President & CFOOfficer |
• – – |
2004-03-11 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
256,410 |
|
- |
|
| HALO |
Halozyme Therapeutics Inc |
Secretary, CFOOfficer |
• – – |
2005-01-18 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
256,410 |
|
- |
|
| HALO |
Halozyme Therapeutics Inc |
VP and Chief Financial Officer |
• – – |
2013-05-20 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
105,000 |
|
- |
|
| HALO |
Halozyme Therapeutics Inc |
VP, Chief Financial Officer |
• – – |
2013-12-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,419 |
243,154 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
VP and Chief Financial Officer |
• – – |
2014-02-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,125 |
246,279 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
VP and Chief Financial Officer |
• – – |
2014-02-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,213 |
248,492 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
VP and Chief Financial Officer |
• – – |
2014-12-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
17,625 |
361,175 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
VP and Chief Financial Officer |
• – – |
2015-02-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,125 |
357,679 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
VP and Chief Financial Officer |
• – – |
2015-02-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,213 |
359,892 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
VP and Chief Financial Officer |
• – – |
2015-02-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,088 |
366,980 |
0 |
- |
|
| SVRA |
Savara Inc |
Director |
– • – |
2017-04-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,142 |
23,570 |
0 |
- |
|
| SVRA |
Savara Inc |
Director |
– • – |
2023-12-14 |
4 |
A |
$0.00 |
$0 |
D/D |
22,500 |
2,223,642 |
0 |
- |
|
| SVRA |
Savara Inc |
Director |
– • – |
2022-12-16 |
4 |
B |
$1.50 |
$512 |
D/D |
341 |
1,946,593 |
2.31 |
% |
|
| SVRA |
Savara Inc |
Director |
– • – |
2022-09-20 |
4 |
B |
$1.45 |
$870 |
D/D |
600 |
1,741,142 |
2.31 |
% |
|
| SVRA |
Savara Inc |
Director |
– • – |
2022-09-06 |
4 |
B |
$1.38 |
$1,201 |
D/D |
870 |
1,702,012 |
2.31 |
% |
|
| SVRA |
Savara Inc |
Director |
– • – |
2022-09-19 |
4 |
B |
$1.46 |
$2,040 |
D/D |
1,400 |
1,740,542 |
2.31 |
% |
|
| SVRA |
Savara Inc |
Director |
– • – |
2019-06-26 |
4 |
B |
$2.38 |
$2,142 |
D/D |
900 |
64,685 |
2.31 |
- |
|
| SVRA |
Savara Inc |
Director |
– • – |
2022-09-07 |
4 |
B |
$1.39 |
$2,950 |
D/D |
2,130 |
1,704,142 |
2.31 |
% |
|
| LJPC |
La Jolla Pharmaceutical C... |
Director |
– • – |
2020-09-08 |
4 |
B |
$3.83 |
$3,830 |
D/D |
1,000 |
48,000 |
2.31 |
% |
|
| SVRA |
Savara Inc |
Director |
– • – |
2022-12-28 |
4 |
B |
$1.50 |
$4,923 |
D/D |
3,293 |
2,065,142 |
2.31 |
% |
|
| SVRA |
Savara Inc |
Director |
– • – |
2022-12-20 |
4 |
B |
$1.48 |
$5,307 |
D/D |
3,586 |
2,004,728 |
2.39 |
% |
|
| SVRA |
Savara Inc |
Director |
– • – |
2012-05-09 |
4 |
B |
$0.55 |
$5,500 |
D/D |
10,000 |
10,000 |
2.39 |
- |
|
| SVRA |
Savara Inc |
Director |
– • – |
2021-05-19 |
4 |
B |
$1.58 |
$7,905 |
D/D |
5,003 |
866,800 |
2.39 |
% |
|
| HALO |
Halozyme Therapeutics Inc |
Secretary, CFO |
• – – |
2005-08-23 |
4 |
B |
$1.68 |
$8,438 |
D/D |
5,000 |
391,410 |
2.74 |
- |
|
| SVRA |
Savara Inc |
Director |
– • – |
2022-09-16 |
4 |
B |
$1.44 |
$8,652 |
D/D |
6,000 |
1,739,142 |
2.39 |
% |
|
93 Records found
|
|
Page 1 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
